{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:18Z","timestamp":1786982118658,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11886-022-01752-y","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T07:07:04Z","timestamp":1660201624000},"page":"1233-1240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Leadless Pacing: Where We Currently Stand and What the Future Holds"],"prefix":"10.1007","volume":"24","author":[{"given":"Rand","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhael F.","family":"El-Chami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"issue":"8","key":"1752_CR1","first-page":"e382","volume":"140","author":"FM Kusumoto","year":"2019","unstructured":"Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC\/AHA\/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2019;140(8):e382\u2013482.","journal-title":"Circulation"},{"issue":"18","key":"1752_CR2","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/eurheartj\/eht511","volume":"35","author":"RE Kirkfeldt","year":"2014","unstructured":"Kirkfeldt RE, Johansen JB, Nohr EA, Jorgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014;35(18):1186\u201394.","journal-title":"Eur Heart J"},{"issue":"5","key":"1752_CR3","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.hrthm.2011.12.014","volume":"9","author":"EO Udo","year":"2012","unstructured":"Udo EO, Zuithoff NP, van Hemel NM, et al. Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm. 2012;9(5):728\u201335.","journal-title":"Heart Rhythm"},{"issue":"11","key":"1752_CR4","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.jacep.2017.05.007","volume":"3","author":"DJ Cantillon","year":"2017","unstructured":"Cantillon DJ, Exner DV, Badie N, et al. Complications and health care costs associated with transvenous cardiac pacemakers in a nationwide assessment. JACC Clin Electrophysiol. 2017;3(11):1296\u2013305.","journal-title":"JACC Clin Electrophysiol"},{"issue":"7","key":"1752_CR5","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.hrthm.2018.04.022","volume":"15","author":"DJ Cantillon","year":"2018","unstructured":"Cantillon DJ, Dukkipati SR, Ip JH, et al. Comparative study of acute and mid-term complications with leadless and transvenous cardiac pacemakers. Heart Rhythm. 2018;15(7):1023\u201330.","journal-title":"Heart Rhythm"},{"issue":"9","key":"1752_CR6","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.hrthm.2018.04.027","volume":"15","author":"FVY Tjong","year":"2018","unstructured":"Tjong FVY, Knops RE, Udo EO, et al. Leadless pacemaker versus transvenous single-chamber pacemaker therapy: a propensity score-matched analysis. Heart Rhythm. 2018;15(9):1387\u201393.","journal-title":"Heart Rhythm"},{"issue":"6","key":"1752_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1056\/NEJMoa1511643","volume":"374","author":"D Reynolds","year":"2016","unstructured":"Reynolds D, Duray GZ, Omar R, et al. A leadless intracardiac transcatheter pacing system. N Engl J Med. 2016;374(6):533\u201341.","journal-title":"N Engl J Med"},{"issue":"12","key":"1752_CR8","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.hrthm.2018.08.005","volume":"15","author":"MF El-Chami","year":"2018","unstructured":"El-Chami MF, Al-Samadi F, Clementy N, et al. Updated performance of the Micra transcatheter pacemaker in the real-world setting: a comparison to the investigational study and a transvenous historical control. Heart Rhythm. 2018;15(12):1800\u20137.","journal-title":"Heart Rhythm"},{"issue":"5","key":"1752_CR9","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.hrthm.2017.01.035","volume":"14","author":"GZ Duray","year":"2017","unstructured":"Duray GZ, Ritter P, El-Chami M, et al. Long-term performance of a transcatheter pacing system: 12-month results from the Micra Transcatheter Pacing Study. Heart Rhythm. 2017;14(5):702\u20139.","journal-title":"Heart Rhythm"},{"issue":"1","key":"1752_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jacep.2021.11.002","volume":"8","author":"VY Reddy","year":"2022","unstructured":"Reddy VY, Exner DV, Doshi R, et al. Primary results on safety and efficacy from the LEADLESS II-Phase 2 worldwide clinical trial. JACC Clin Electrophysiol. 2022;8(1):115\u20137.","journal-title":"JACC Clin Electrophysiol"},{"key":"1752_CR11","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Hauser RG, Gornick CC, Abdelhadi RH, Tang CY, Casey SA, Sengupta JD. Major adverse clinical events associated with implantation of a leadless intracardiac pacemaker. Heart Rhythm. 2021;18(7):1132\u20131139.\u00a0Findings from this study suggest that perforation with Leadless pacemakers is associated with more adverse outcomes and need for surgery.","DOI":"10.1016\/j.hrthm.2021.03.015"},{"issue":"6","key":"1752_CR12","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.hrthm.2022.01.028","volume":"19","author":"EFJ Oosterwerff","year":"2022","unstructured":"Oosterwerff EFJ, Salavati A, Lenssen M, Delnoy PP, Adiyaman A, Elvan A. Experience with malfunctioning leadless pacemakers: troubleshooting and management during medium-term follow-up. Heart Rhythm. 2022;19(6):894\u2013900.","journal-title":"Heart Rhythm"},{"issue":"12","key":"1752_CR13","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.hrthm.2017.07.004","volume":"14","author":"D Lakkireddy","year":"2017","unstructured":"Lakkireddy D, Knops R, Atwater B, et al. A worldwide experience of the management of battery failures and chronic device retrieval of the Nanostim leadless pacemaker. Heart Rhythm. 2017;14(12):1756\u201363.","journal-title":"Heart Rhythm"},{"issue":"12","key":"1752_CR14","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1056\/NEJMoa1507192","volume":"373","author":"VY Reddy","year":"2015","unstructured":"Reddy VY, Exner DV, Cantillon DJ, et al. Percutaneous implantation of an entirely intracardiac leadless pacemaker. N Engl J Med. 2015;373(12):1125\u201335.","journal-title":"N Engl J Med"},{"issue":"9","key":"1752_CR15","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.hrthm.2017.05.017","volume":"14","author":"PR Roberts","year":"2017","unstructured":"Roberts PR, Clementy N, Al Samadi F, et al. A leadless pacemaker in the real-world setting: the Micra Transcatheter Pacing System Post-Approval Registry. Heart Rhythm. 2017;14(9):1375\u20139.","journal-title":"Heart Rhythm"},{"key":"1752_CR16","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Piccini JP, El-Chami M, Wherry K, et al. Contemporaneous comparison of outcomes among patients implanted with a leadless vs transvenous single-chamber ventricular pacemaker. JAMA Cardiol. 2021;6(10):1187\u20131195.\u00a0Real-world date show that leadless pacemakers are associated with lower device related complications but higher rate of perforation.","DOI":"10.1001\/jamacardio.2021.2621"},{"key":"1752_CR17","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 El-Chami MF, Bockstedt L, Longacre C, et al. Leadless vs. transvenous single-chamber ventricular pacing in the Micra CED study: 2-year follow-up. Eur Heart J. 2022;43(12):1207\u20131215. https:\/\/doi.org\/10.1093\/eurheartj\/ehab767.\u00a0This study shows that during intermediate term follow-up, leadless pacemakers are associated with lower rate of complications mainly driven by lower need for lead revisions.","DOI":"10.1093\/eurheartj\/ehab767"},{"issue":"1","key":"1752_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jacep.2019.10.017","volume":"6","author":"C Steinwender","year":"2020","unstructured":"Steinwender C, Khelae SK, Garweg C, et al. Atrioventricular synchronous pacing using a leadless ventricular pacemaker: results from the MARVEL 2 study. JACC Clin Electrophysiol. 2020;6(1):94\u2013106.","journal-title":"JACC Clin Electrophysiol"},{"issue":"5","key":"1752_CR19","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.hrthm.2022.01.024","volume":"19","author":"KTN Breeman","year":"2022","unstructured":"Breeman KTN, Swackhamer B, Brisben AJ, et al. Long-term performance of a novel communicating antitachycardia pacing-enabled leadless pacemaker and subcutaneous implantable cardioverter-defibrillator system: a comprehensive preclinical study. Heart Rhythm. 2022;19(5):837\u201346.","journal-title":"Heart Rhythm"},{"issue":"5","key":"1752_CR20","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.hrthm.2022.01.021","volume":"19","author":"M Rashtian","year":"2022","unstructured":"Rashtian M, Banker RS, Neuzil P, et al. Preclinical safety and electrical performance of novel atrial leadless pacemaker with dual-helix fixation. Heart Rhythm. 2022;19(5):776\u201381.","journal-title":"Heart Rhythm"},{"issue":"8","key":"1752_CR21","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/europace\/eut124","volume":"15","author":"A Auricchio","year":"2013","unstructured":"Auricchio A, Delnoy PP, Regoli F, et al. First-in-man implantation of leadless ultrasound-based cardiac stimulation pacing system: novel endocardial left ventricular resynchronization therapy in heart failure patients. Europace. 2013;15(8):1191\u20137.","journal-title":"Europace"},{"issue":"17","key":"1752_CR22","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.jacc.2017.02.059","volume":"69","author":"VY Reddy","year":"2017","unstructured":"Reddy VY, Miller MA, Neuzil P, et al. Cardiac resynchronization therapy with wireless left ventricular endocardial pacing: the SELECT-LV study. J Am Coll Cardiol. 2017;69(17):2119\u201329.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1752_CR23","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.hrthm.2020.03.002","volume":"17","author":"BJ Sieniewicz","year":"2020","unstructured":"Sieniewicz BJ, Betts TR, James S, et al. Real-world experience of leadless left ventricular endocardial cardiac resynchronization therapy: a multicenter international registry of the WiSE-CRT pacing system. Heart Rhythm. 2020;17(8):1291\u20137.","journal-title":"Heart Rhythm"},{"issue":"5","key":"1752_CR24","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/europace\/euaa342","volume":"23","author":"A Carabelli","year":"2021","unstructured":"Carabelli A, Jabeur M, Jacon P, et al. European experience with a first totally leadless cardiac resynchronization therapy pacemaker system. Europace. 2021;23(5):740\u20137.","journal-title":"Europace"},{"key":"1752_CR25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ahj.2021.02.008","volume":"235","author":"JP Singh","year":"2021","unstructured":"Singh JP, Walsh MN, Kubo SH, et al. Modified design of stimulation of the left ventricular endocardium for cardiac resynchronization therapy in nonresponders, previously untreatable and high-risk upgrade patients (SOLVE-CRT) trial. Am Heart J. 2021;235:158\u201362.","journal-title":"Am Heart J"},{"issue":"4","key":"1752_CR26","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.hrcr.2016.04.006","volume":"2","author":"A Koay","year":"2016","unstructured":"Koay A, Khelae S, Wei KK, Muhammad Z, Mohd Ali R, Omar R. Treating an infected transcatheter pacemaker system via percutaneous extraction. HeartRhythm Case Rep. 2016;2(4):360\u20132.","journal-title":"HeartRhythm Case Rep"},{"issue":"8","key":"1752_CR27","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.hrthm.2020.03.019","volume":"17","author":"MF El-Chami","year":"2020","unstructured":"El-Chami MF, Bonner M, Holbrook R, et al. Leadless pacemakers reduce risk of device-related infection: review of the potential mechanisms. Heart Rhythm. 2020;17(8):1393\u20137.","journal-title":"Heart Rhythm"},{"issue":"31","key":"1752_CR28","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1093\/eurheartj\/ehw137","volume":"37","author":"R Borgquist","year":"2016","unstructured":"Borgquist R, Ljungstrom E, Koul B, Hoijer CJ. Leadless Medtronic Micra pacemaker almost completely endothelialized already after 4 months: first clinical experience from an explanted heart. Eur Heart J. 2016;37(31):2503.","journal-title":"Eur Heart J"},{"issue":"7","key":"1752_CR29","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1111\/jce.14517","volume":"31","author":"MF El-Chami","year":"2020","unstructured":"El-Chami MF, Mayotte J, Bonner M, Holbrook R, Stromberg K, Sohail MR. Response to the letter to the editor: wettability and roughness: important determinants of bacterial adhesion and biofilm formation. J Cardiovasc Electrophysiol. 2020;31(7):1886\u20137.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"8","key":"1752_CR30","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/pace.13752","volume":"42","author":"MF El-Chami","year":"2019","unstructured":"El-Chami MF, Soejima K, Piccini JP, et al. Incidence and outcomes of systemic infections in patients with leadless pacemakers: data from the Micra IDE study. Pacing Clin Electrophysiol. 2019;42(8):1105\u201310.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"1","key":"1752_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1161\/CIRCEP.114.002199","volume":"8","author":"MR Sohail","year":"2015","unstructured":"Sohail MR, Palraj BR, Khalid S, et al. Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB). Circ Arrhythm Electrophysiol. 2015;8(1):137\u201344.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"4","key":"1752_CR32","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/jce.13851","volume":"30","author":"MF El-Chami","year":"2019","unstructured":"El-Chami MF, Johansen JB, Zaidi A, et al. Leadless pacemaker implant in patients with pre-existing infections: results from the Micra postapproval registry. J Cardiovasc Electrophysiol. 2019;30(4):569\u201374.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"3","key":"1752_CR33","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/jce.13140","volume":"28","author":"M Vamos","year":"2017","unstructured":"Vamos M, Erath JW, Benz AP, Bari Z, Duray GZ, Hohnloser SH. Incidence of cardiac perforation with conventional and with leadless pacemaker systems: a systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2017;28(3):336\u201346.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"4","key":"1752_CR34","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/pace.12804","volume":"39","author":"P Omdahl","year":"2016","unstructured":"Omdahl P, Eggen MD, Bonner MD, Iaizzo PA, Wika K. Right ventricular anatomy can accommodate multiple Micra transcatheter pacemakers. Pacing Clin Electrophysiol. 2016;39(4):393\u20137.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"2","key":"1752_CR35","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/jce.14825","volume":"32","author":"NK Bhatia","year":"2021","unstructured":"Bhatia NK, Kiani S, Merchant FM, et al. Life cycle management of Micra transcatheter pacing system: data from a high-volume center. J Cardiovasc Electrophysiol. 2021;32(2):484\u201390.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"1","key":"1752_CR36","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.1038\/s41467-021-24417-w","volume":"12","author":"H Ryu","year":"2021","unstructured":"Ryu H, Park HM, Kim MK, et al. Self-rechargeable cardiac pacemaker system with triboelectric nanogenerators. Nat Commun. 2021;12(1):4374.","journal-title":"Nat Commun"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-022-01752-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-022-01752-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-022-01752-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T19:11:12Z","timestamp":1665601872000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-022-01752-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1752"],"URL":"https:\/\/doi.org\/10.1007\/s11886-022-01752-y","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,11]]},"assertion":[{"value":"15 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Mikhael El-Chami is a consultant for Medtronic and Boston Scientific. The other authors have no conflict of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}